Soichi Fumita

Safety and efficacy of nivolumab in combination with S-1/capecitabine plus oxaliplatin in patients with previously untreated, unresectable, advanced, or recurrent gastric/gastroesophageal junction cancer: interim results of a randomized, phase II trial (ATTRACTION-4)

Narikazu Boku, Min‐Hee Ryu, Ken Kato et al. · Annals of Oncology · 2018 · 317 citations · Full text

Clinical Application of the FoundationOne CDx Assay to Therapeutic Decision-Making for Patients with Advanced Solid Tumors

Masayuki Takeda, Takayuki Takahama, Kazuko Sakai et al. · The Oncologist · 2020 · 93 citations · Full text

Roles of BIM induction and survivin downregulation in lapatinib-induced apoptosis in breast cancer cells with HER2 amplification

Junko Tanizaki, Isamu Okamoto, Soichi Fumita et al. · Oncogene · 2011 · 67 citations

Bim Induction, Cell Regulation, Medicine +11

High-dose dexamethasone plus antihistamine prevents colorectal cancer patients treated with modified FOLFOX6 from hypersensitivity reactions induced by oxaliplatin

Yasuhiro Kidera, Taroh Satoh, Shinya Ueda et al. · International Journal of Clinical Oncology · 2011 · 42 citations

Modified Folfox6, Oncology, Allergy +8

Incidence of opioid‐induced constipation in Japanese patients with cancer pain: A prospective observational cohort study

Akihiro Tokoro, Hisao Imai, Soichi Fumita et al. · Cancer Medicine · 2019 · 42 citations · Full text